vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and TOMPKINS FINANCIAL CORP (TMP). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $194.8M, roughly 1.8× TOMPKINS FINANCIAL CORP). TOMPKINS FINANCIAL CORP runs the higher net margin — 49.4% vs -0.8%, a 50.2% gap on every dollar of revenue. On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs 9.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $31.9M). Over the past eight quarters, TOMPKINS FINANCIAL CORP's revenue compounded faster (63.6% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.
ASIX vs TMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $194.8M |
| Net Profit | $-2.8M | $96.2M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 71.7% |
| Net Margin | -0.8% | 49.4% |
| Revenue YoY | 9.4% | 152.7% |
| Net Profit YoY | -892.9% | 388.9% |
| EPS (diluted) | $-0.11 | $6.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $194.8M | ||
| Q3 25 | $374.5M | $87.4M | ||
| Q2 25 | $410.0M | $82.6M | ||
| Q1 25 | $377.8M | $81.7M | ||
| Q4 24 | $329.1M | $77.1M | ||
| Q3 24 | $398.2M | $76.6M | ||
| Q2 24 | $453.5M | $72.7M | ||
| Q1 24 | $336.8M | $72.8M |
| Q4 25 | $-2.8M | $96.2M | ||
| Q3 25 | $-2.6M | $23.7M | ||
| Q2 25 | $31.4M | $21.5M | ||
| Q1 25 | $23.3M | $19.7M | ||
| Q4 24 | $352.0K | $19.7M | ||
| Q3 24 | $22.3M | $18.6M | ||
| Q2 24 | $38.9M | $15.7M | ||
| Q1 24 | $-17.4M | $16.9M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 71.7% | ||
| Q3 25 | -0.9% | 35.6% | ||
| Q2 25 | 7.7% | 34.2% | ||
| Q1 25 | 7.7% | 31.6% | ||
| Q4 24 | -3.9% | 33.4% | ||
| Q3 24 | 7.5% | 32.0% | ||
| Q2 24 | 11.5% | 28.3% | ||
| Q1 24 | -7.0% | 30.4% |
| Q4 25 | -0.8% | 49.4% | ||
| Q3 25 | -0.7% | 27.1% | ||
| Q2 25 | 7.7% | 26.0% | ||
| Q1 25 | 6.2% | 24.1% | ||
| Q4 24 | 0.1% | 25.5% | ||
| Q3 24 | 5.6% | 24.3% | ||
| Q2 24 | 8.6% | 21.6% | ||
| Q1 24 | -5.2% | 23.2% |
| Q4 25 | $-0.11 | $6.72 | ||
| Q3 25 | $-0.10 | $1.65 | ||
| Q2 25 | $1.15 | $1.50 | ||
| Q1 25 | $0.86 | $1.37 | ||
| Q4 24 | $0.02 | $1.39 | ||
| Q3 24 | $0.82 | $1.30 | ||
| Q2 24 | $1.43 | $1.10 | ||
| Q1 24 | $-0.65 | $1.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $132.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $938.4M |
| Total Assets | $1.7B | $8.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $132.8M | ||
| Q3 25 | $23.7M | $193.5M | ||
| Q2 25 | $18.4M | $212.6M | ||
| Q1 25 | $8.3M | $193.1M | ||
| Q4 24 | $19.6M | $134.4M | ||
| Q3 24 | $17.3M | $132.3M | ||
| Q2 24 | $12.1M | $70.9M | ||
| Q1 24 | $20.6M | $57.1M |
| Q4 25 | $815.2M | $938.4M | ||
| Q3 25 | $818.2M | $788.8M | ||
| Q2 25 | $823.7M | $761.8M | ||
| Q1 25 | $794.4M | $741.4M | ||
| Q4 24 | $774.6M | $713.4M | ||
| Q3 24 | $766.4M | $719.9M | ||
| Q2 24 | $746.6M | $674.6M | ||
| Q1 24 | $713.2M | $667.9M |
| Q4 25 | $1.7B | $8.7B | ||
| Q3 25 | $1.7B | $8.5B | ||
| Q2 25 | $1.6B | $8.4B | ||
| Q1 25 | $1.6B | $8.2B | ||
| Q4 24 | $1.6B | $8.1B | ||
| Q3 24 | $1.5B | $8.0B | ||
| Q2 24 | $1.5B | $7.9B | ||
| Q1 24 | $1.5B | $7.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $38.9M |
| Free Cash FlowOCF − Capex | $36.1M | $31.9M |
| FCF MarginFCF / Revenue | 10.0% | 16.4% |
| Capex IntensityCapex / Revenue | 7.7% | 3.6% |
| Cash ConversionOCF / Net Profit | — | 0.40× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $105.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $38.9M | ||
| Q3 25 | $26.6M | $34.9M | ||
| Q2 25 | $21.1M | $18.9M | ||
| Q1 25 | $11.4M | $22.2M | ||
| Q4 24 | $64.2M | $95.0M | ||
| Q3 24 | $57.3M | $21.2M | ||
| Q2 24 | $50.2M | $27.3M | ||
| Q1 24 | $-36.2M | $23.2M |
| Q4 25 | $36.1M | $31.9M | ||
| Q3 25 | $66.0K | $33.9M | ||
| Q2 25 | $-7.2M | $18.3M | ||
| Q1 25 | $-22.6M | $20.9M | ||
| Q4 24 | $29.8M | $88.8M | ||
| Q3 24 | $26.8M | $18.9M | ||
| Q2 24 | $16.7M | $26.3M | ||
| Q1 24 | $-71.6M | $21.9M |
| Q4 25 | 10.0% | 16.4% | ||
| Q3 25 | 0.0% | 38.8% | ||
| Q2 25 | -1.7% | 22.1% | ||
| Q1 25 | -6.0% | 25.5% | ||
| Q4 24 | 9.1% | 115.1% | ||
| Q3 24 | 6.7% | 24.7% | ||
| Q2 24 | 3.7% | 36.2% | ||
| Q1 24 | -21.3% | 30.0% |
| Q4 25 | 7.7% | 3.6% | ||
| Q3 25 | 7.1% | 1.1% | ||
| Q2 25 | 6.9% | 0.8% | ||
| Q1 25 | 9.0% | 1.7% | ||
| Q4 24 | 10.4% | 8.1% | ||
| Q3 24 | 7.7% | 2.9% | ||
| Q2 24 | 7.4% | 1.3% | ||
| Q1 24 | 10.5% | 1.9% |
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | 0.67× | 0.88× | ||
| Q1 25 | 0.49× | 1.13× | ||
| Q4 24 | 182.29× | 4.82× | ||
| Q3 24 | 2.57× | 1.14× | ||
| Q2 24 | 1.29× | 1.74× | ||
| Q1 24 | — | 1.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
TMP
Segment breakdown not available.
